We use cookies on this site to enhance your experience.
By selecting “Accept” and continuing to use this website, you consent to the use of cookies.
B.Sc (Tianjin University of Finance and Economics), M.Sc (Tianjin University of Finance and Economics), Ph.D (Concordia University).
CPA/CGA.
Dr. Xu’s research focuses on dynamics of market valuation, corporate disclosure, corporate social responsibility and big data mining/analysis. She also works on intangible assets and stakeholder -related topics. Her research has been funded by the Social Sciences and Humanities Research Council of Canada, Deloitte and Canadian Academic Accounting Association Research Grant and Canadian Institute of Chartered Accountants and Canadian Academic Accounting Association Research Grant. Her work has appeared in many academic journals, including Contemporary Accounting Research, Information and Management, Journal of Business Research, Review of Quantitative Finance and Accounting, and Issues in Accounting Education. Her current research projects address CEO compensation, stakeholder management, decision-making for risk projects and firm multi-step disclosure strategy.
Research Interests:
Market valuation models, corporate disclosures, corporate relationships, and big data analysis.
Ongoing Projects:
- “Website Usage as a Critical Factor in Firm Innovation Success” with F. Wang.
- “Market reaction to multi-step information disclosures in the Biotechnology Industry” with B. McConomy
- “Positioning Canada to compete in the global market for clinical trial” with E. Maier
Supervised one Ph.D. dissertation.
- “Who Needs to Be More Visible Online? The Value Implications of Web Visibility and Firm Heterogeneity, Information & Management. 54(4), 506-515, 2017, with F. Wang
- “Information Traffic and Information Effectiveness”, Journal of Emerging Technologies in Accounting, Vol. 13(2), 21-36, 2016, with Z. Huang
- “R&D Innovation and the Value of Cash in the Biotech Industry” Journal of Business Research, 26 (7), 750-755, 2009.
- “Deflator Selection and Generalized Linear Modeling in Market-based Accounting Research”, Applied Financial Economics, 18 (21), 1739-1753, 2008, with C. Wu.
- “The Stock Market Valuation of R&D Information in Biotech Firms, Contemporary Accounting Research, 24 (4), 1291-1318, 2007, with Michele Magnan, and Paul Andre
- “R&D Progress, Stock Price Volatility, and Post-Announcement Drift: An Empirical Investigation into Biotech Firms, Review of Quantitative Finance and Accounting 26 (4), 391-408, 2006.